436
Mean arterial pressure (MAP), 345
Medium methoxylatedpectin (MMP), 158
Methylation, 100, 144
Microbial enzymes, 235, 319
Microbial fermentation, 237
Microbial proteases, 321
Microfluidisation, 366, 367
Microorganisms, 319
Microwave-assisted extraction (MAE),
135, 150
Microwave extraction, 99
Modern agricultural practices, 408
Modern mass spectrometry, 405
Modification of lipids
consumption of oils, 405
as genetic modification, 406
long chain PUFAs, 405
methods
animal fats, 409
blending, 407
fractionation, 407
hydrogenation, 407
interesterification, 406, 408
seed breeding, 409
technological procedures, 406
usage, 406
nutritional requirements, 405
Monounsaturated fatty acids, 397
Mucoadhesion, 187
Multidimensional Protein Identification
Technology (MudPIT), 289
N
Nanoelements, 75, 77
Nanoemulsification, 365
Nanoparticles, 75
Nano-precipitation method, 190
Nano-spray drying, 368
Nanotechnology, 62
Native structure, 301
Neurotransmitters, 251
New instrumental imaging techniques, 205
Nitrocellulose (NC), 283
Non-covalent bonds
electrostatic interactions, 216, 217
hydrophobic interactions, 216
Nuclear magnetic resonance (NMR)
spectroscopy, 100, 238, 400
alternative approach, 314
amino acids, 314
case 19F resonance, 314
characterization, 314
definition, 313
histidine, 314
homo/hetero nuclear, 313
multidimensional, 314
photo CIDNP, 315
Nutraceutical potential RS
anti-cancerous properties, 47–49
hypoglycemic properties, 49–51
hypolipidemic properties, 51–53
mineral absorption, 53–54
prebiotic, 45–47
Nutraceutical properties
anticancerous property, 110, 111
anti-hypercholesterolemic property, 109
anti-oxidant property, 106, 107
beneficial health products, 413
bile stone formation, 421
biological properties, 106
fats and lipids, 413
foods, 413
hypocholesterolemic effects, 425, 426
hypoglyceamic property, 109, 110
immuno-modulatory property, 108
lipids, 414
mineral absorption
fat-soluble vitamin, 422
vitamin A, 422
vitamin D, 423, 424
vitamin E, 424
vitamin K, 424, 425
research-oriented sector, 413
sources and bioactivity, 107
treatment, 413
O
Octenyl succinic anhydride (OSA), 65, 78
Oils, 392, 393
Oligosaccharides, 73
Opioid peptides
agonist/antagonist effect, 258
endogenous, 258
exogenous, 258
κ-casein, 258
milk-derived, 257, 258
tetrapeptides, 258
whey protein’s primary structure, 258
Organic solvents, 402
Oxidized starch (OS), 80
P
Paprika red pigment (PRP), 363
Peak viscosity (PV), 9
Pectic oligosaccharides, 155
Index
Précédent

- 430/435

Suivant